Elevated Cancer Prevalence Identified at Specific Anatomical Sites Among People With Myotonic Dystrophy Using a Population‐Based Sample
Muscle & Nerve · 2025-10 · 72 (4) · 570-579
DOI: 10.1002/mus.28464 ↗Kurz gefasst
Fachartikel in der Zeitschrift Muscle & Nerve, online erschienen am 30.06.2025. Verfasst von Wanfang Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, University of South Carolina, Columbia, South Carolina, USA. Hauptthemen laut MEDLINE: Myotonic Dystrophy, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: CDC HHS, NINDS NIH HHS, NCBDD CDC HHS.
Abstract (Originalsprache)
Introduction/Aim To optimize patient care and cancer screening in myotonic dystrophy (DM), it is crucial to clarify cancer risks by DM type to guide targeted screening and prevention efforts. This study describes the prevalence of cancer among individuals diagnosed with DM from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet), and compares it to cancer prevalence in the US Surveillance, Epidemiology, and End Result (SEER) data.
Methods
This retrospective cohort study used 2008–2019 medical records data on 1229 individuals diagnosed with DM (DM1: 81.4%, DM2: 9.4%, DM‐not otherwise specified [NOS]: 9.2%) from MD STARnet. Age‐ and sex‐specific cancer prevalence rates from SEER were applied to the MD STARnet data to calculate 12‐year limited duration (LD) and complete standardized prevalence ratios (SPR) for total cancer and by primary cancer site.
Results
Over a 12‐year span, individuals with DM1 had a 4.01‐fold higher LD prevalence of thyroid cancer and a 17.97‐fold higher LD prevalence of nonmelanoma skin cancer compared to the SEER prevalence, respectively. Complete prevalence assessments identified that individuals with DM1 had a 4.18‐fold higher prevalence of thyroid cancer, a 2.36‐fold higher prevalence of melanoma, and a 4.68‐fold higher prevalence of ovarian cancer. For DM2, the study observed a 34.02‐fold higher LD prevalence for nonmelanoma skin cancer. Additionally, a significantly elevated complete prevalence of breast cancer (2.65‐fold) was noted for DM2 compared to SEER data.
Discussion
Future research with larger cohorts is needed to define cancer risks by DM subtype and investigate underlying biological mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology and Biostatistics, University of South Carolina, Columbia, South Carolina, USA.
- Biostatistics Center, George Washington University, Washington, DC, USA.
- Department of Neurology, Virginia Commonwealth University, Richmond, Virginia, USA.
- RTI International, Research Triangle Park, North Carolina, USA.
- Department of Environmental, Occupational, and Geospatial Health Sciences, Graduate School of Public Health & Health Policy, City University of New York, New York, New York, USA.
- Division of Population Health Surveillance, Department of Health, Bureau of Maternal and Child Health, Columbia, South Carolina, USA.
ORCID-Profile: Wanfang Zhang, Nicholas E Johnson, Daria McMahon
Förderung
- CDC HHS
- NINDS NIH HHS
- NCBDD CDC HHS
- Centers for Disease Control and Prevention
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Zhang, W., Bhandaru, V., Johnson, N. E., Moore, A., Lyons, A., Berry, R., Westfield, C., McMahon, D., Soim, A., Cai, B., McDermott, S., & MD STARnet (2025). Elevated Cancer Prevalence Identified at Specific Anatomical Sites Among People With Myotonic Dystrophy Using a Population‐Based Sample. Muscle & Nerve, 72(4), 570-579. https://doi.org/10.1002/mus.28464
Vancouver
Zhang W, Bhandaru V, Johnson NE, Moore A, Lyons A, Berry R, et al. Elevated Cancer Prevalence Identified at Specific Anatomical Sites Among People With Myotonic Dystrophy Using a Population‐Based Sample. Muscle & Nerve. 2025;72(4):570-579. doi:10.1002/mus.28464
BibTeX
@article{Zhang2025,
author = {Zhang, Wanfang and Bhandaru, Vinay and Johnson, Nicholas E and Moore, Amy and Lyons, Abigail and Berry, Reba and Westfield, Christina and McMahon, Daria and Soim, Aida and Cai, Bo and McDermott, Suzanne and MD STARnet, MD STARnet},
title = {Elevated Cancer Prevalence Identified at Specific Anatomical Sites Among People With Myotonic Dystrophy Using a Population‐Based Sample},
journal = {Muscle & Nerve},
year = {2025},
volume = {72},
number = {4},
pages = {570--579},
doi = {10.1002/mus.28464}
}
EUVIMED